Pharma & lifesciences
Pharma & lifesciences
Meest gelezen
- Liberalisation of the Distribution of Medical Devices (NautaDutilh)
- Access to Medicine Index (Access to Medicine Foundation)
- Can a Member State in times of Corona crisis prohibit a pharmaceutical company to deliver certain products (such as testing kits or protective medical gear) to other EU countries? (Altius)
With national governments scrambling to take measures in order to counter the Covid-19 pandemic, we are...
With the Corona crisis, countries such as Germany, France and the Czech Republic have already announced...
Het koninklijk besluit van 11 juni 2015 verbiedt om officinale (vrije verkoop) of magistrale bereidingen af...
On 7 February 2019, the federal government submitted a bill regarding the reimbursement of pharmaceutical specialties...
Until recently, certain medical devices could only be distributed in Belgium through limited channels (pharmacies or...
Wearable watches that help consumers obtain a better understanding of their eating patterns; wearable clothes that...
Since 25 May 2018, the General Data Protection Regulation (“GDPR”) is applicable throughout Europe. Strictly regulating...
Op 12 februari 2018 aanvaardde het hof van beroep te Antwerpen voor de eerste maal (voor zover...
On 28 May, the European Commission adopted the long-awaited Implementing Regulation 2018/775 (‘Implementing Regulation’) laying down...
Following the increasing difficulties with the enforcement of the legislative framework applicable to Food for Special...
Software, of which at least one of the functions makes it possible to use patient-specific data...
The discovery of Fipronil residue in chicken eggs due to the use of Fipronil as an...
The EU Regulatory Committee on Medical Devices recently voted in favor of the European Commission’s draft decision on...
From 19 October 2017, use of the electronic Trade Control and Expert System (“TRACES”) will become...
On 23 June 2017, the Belgian Official Journal contained the Royal Decree of 14 June 2017 implementing the...
On 15 May 2017, the European Commission opened a formal investigation into the pricing of medicines....
On 8 June 2017, the Court of Justice of the European Union (“CJEU”) confirmed that a...
On 22 May 2017, the new Belgian law of 7 May 2017 on clinical trials on...
On 31 May 2017, the European Medicines Agency (EMA) and the European Commission (EC) published the first...
The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Decision on the qualification...
Vacatures
Intersentia (september 2019)